Trial intelligence / Profile preview

In vitro efficacy of pro- and anticoagulant therapy in plasma from cirrhosis patients undergoing liver transplantation

NL-OMON42693Active, not recruiting

Sponsor
University Medical Center Groningen
Start
Sep 2015
Countries
1
01

Overview

Open-label trial in Bleeding and thrombosis (2 arms), sponsored by University Medical Center Groningen. Primary endpoints: Thrombin generation lag time, Time to peak thrombin generation and 2 more. Started Sep 2015; status: active, not recruiting.

02

Conditions

Bleedingthrombosis

Beyond the preview

Go deeper on NL-OMON42693.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON42693.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call